Sunday, September 20, 2009 3:03:53 AM
http://www.nasdaq.com/aspx/company-news-story.aspx?storyid=200909181720rttraderusequity_0917&title=nucryst-pharma-gets-deficiency-notice-from-nasdaq---quick-facts
(RTTNews) - Nucryst Pharmaceuticals Corp. (NCST) said that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share. In accordance with Marketplace Rule, the company has until March 15, 2010 to regain compliance, which requires a closing bid price of the company's common stock at or above $1.00 per share for a minimum of 10 consecutive business days.
http://www.nasdaq.com/aspx/company-news-story.aspx?storyid=200909181720rttraderusequity_0917&title=nucryst-pharma-gets-deficiency-notice-from-nasdaq---quick-facts
Closed at $0.96 on Friday. Back in March of this year NCST was at $0.30. Sure hope this uptrend continues.
cooler
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM